HINGE HEALTH INC-A
HNGENYSETrading Snapshot
- Day Range
- $441.73 β $453.17
- 52-Week Range
- $30.08 β $97.75
- Volume
- $2.47B
- Avg Volume
- $3.06B
- Shares Outstanding
- 77.4M
- Next Earnings
- Nov 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $588M
- Last Q Revenue
- $213M
- P/E Ratio
- 70.4
- P/S Ratio
- 10.2x
- EPS (TTM)
- $1.38
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +8.4%
Why Investors Own HNGE
- βHigh-growth profile β revenue up -5.3% YoY with expanding US Equity exposure.
- βHealthy economics β 76% gross margin and 11% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
HINGE HEALTH INC-A
HNGEAbout HINGE HEALTH INC-A
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
HINGE HEALTH INC-A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift HNGE price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
HINGE HEALTH INC-A announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.